Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
D000328:Adult; D000818:Animals; D000891:Anti-Infective Agents, Local; D002056:Burns / Q000150:complications* / Q000188:drug therapy; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008887:Military Medicine; D011552:Pseudomonas Infections / Q000188:drug therapy*; D012834:Silver / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D013411:Sulfadiazine; D012834:Silver